CI
PRCT icon

CPMG Inc’s Procept Biorobotics PRCT Stock Holding History

CPMG Inc’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.7M Buy
+426,262
New +$12M 28.75% 2
2024
Q4 		– Sell
-958,334
Closed -$76.8M – 3
2024
Q3 		$76.8M Hold
958,334
– – 67.1% 1
2024
Q2 		$58.5M Sell
958,334
-4,370,533
-82% -$260M 87.55% 1
2024
Q1 		$263M Hold
5,328,867
– – 95.57% 1
2023
Q4 		$223M Hold
5,328,867
– – 97.26% 1
2023
Q3 		$175M Hold
5,328,867
– – 95.6% 1
2023
Q2 		$188M Hold
5,328,867
– – 37.79% 2
2023
Q1 		$151M Hold
5,328,867
– – 30.53% 2
2022
Q4 		$221M Sell
5,328,867
-3,726,474
-41% -$160M 55.58% 1
2022
Q3 		$375M Sell
9,055,341
-1,863,052
-17% -$74.3M 73.64% 1
2022
Q2 		$357M Hold
10,918,393
– – 71.7% 1
2022
Q1 		$382M Sell
10,918,393
-304,269
-3% -$7.32M 64.08% 1
2021
Q4 		$281M Hold
11,222,662
– – 51.76% 1
2021
Q3 		$428M Buy
+11,222,662
New +$431M 47.21% 1

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CPMG Inc's PRCT Position: Q1 2026 in Review

CPMG Inc opened a new position in Procept Biorobotics (PRCT) in Q1 2026: 426,262 shares worth $10.7M. The stake represents 28.75% of the portfolio and ranks #2 among its holdings. This is a return to the name: CPMG Inc previously reported a position in PRCT as recently as Q3 2024.

CPMG Inc first reported a position in PRCT in Q3 2021 and has held it in 14 quarters since. The position peaked at $428M in Q3 2021. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • CPMG Inc held 426,262 shares of Procept Biorobotics worth $10.7M as of Q1 2026.
  • Procept Biorobotics was a new CPMG Inc position in Q1 2026.
  • Procept Biorobotics made up 28.75% of CPMG Inc's portfolio in Q1 2026, its #2 holding.
  • CPMG Inc first reported a position in Procept Biorobotics in Q3 2021 and has held it in 14 quarters since.
  • CPMG Inc's Procept Biorobotics position peaked at $428M in Q3 2021.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on CPMG Inc's 13F filing for Q1 2026, filed 15 May 2026.